Manufacturer of patient monitoring products, Masimo Corp. (MAS) recently announced Food and Drug Administration (FDA)’s clearance of the company’s Radius-7 wireless monitor, under section 510(k).
The Radius-7 monitor, with Masimo's rainbow SET technology, is designed to monitor patients continuously with freedom of movement. The monitor will use Masimo Patient SafetyNet remote monitoring system to alert physicians of dire changes in the patient’s oxygen saturation and pulse rate.
The lightweight Radius-7 monitor reduces the need for nursing support as the monitor does not require disconnection and reconnection of cables. The wireless communication functionality of the Radius-7 monitor allows uninterrupted monitoring of patients even if they are not in bed.
It is believed that a patient takes more time to recover if he/she is immobile and is restricted to the bed. Thus, the Radius-7 monitor, in allowing complete mobility of patients without disruptions in monitoring, will certainly help in their speedy recovery.
Apart from the Radius-7 wearable wireless Rainbow Pulse Co-Oximeter and respiration monitor, the company continues to introduce new products like O3 regional oximetry, iSpO2 Mobile health pulse oximeter for Android, transflectance adhesive forehead pulse oximetry sensor, DCI-mini SpHb for infants and small children SpHb monitoring.
However, the monitoring products market remains quite competitive with a lot of companies vying for substantial market share. Masimo faces stiff competition from the likes of Covidien (COV), Natus Medical (BABY) and CAS Medical Systems (CASM).
Masimo currently retains a Zacks Rank #3 (Hold).
(We are reissuing this article to correct an inaccuracy. The original article, issued December 3, 2014, should no longer be relied upon.)
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment